UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022553 |
|---|---|
| Receipt number | R000025991 |
| Scientific Title | A phase II trial on efficacy and safety of osimertinib in elderly EGFR T790M-positive non-small-cell lung cancer patients who progressed during prior EGFR-TKI treatment or had recurrence |
| Date of disclosure of the study information | 2016/07/03 |
| Last modified on | 2022/04/08 15:05:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/05/31 14:55:10 | ||
| 2 | Update | 2016/09/08 18:18:10 | Recruitment status |
|
| 3 | Update | 2017/12/18 09:55:50 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2018/07/05 11:07:27 | Recruitment status |
|
| 5 | Update | 2018/12/03 10:44:03 | Recruitment status Publication of results |
|
| 6 | Update | 2022/04/08 15:00:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2022/04/08 15:05:44 | Recruitment status Date of IRB Last follow-up date |
